Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00026624
First received: November 12, 2001
Last updated: May 16, 2012
Last verified: May 2012